Peak6 Investments LLC Galapagos Nv Put Options Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 11, 2022	SELL	$47.03 - $57.12 $9,406 - $11,424	-200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$76.15 - $111.94 $15,230 - $22,388	200 New	200 $15,000
Q1 2020 May 14, 2020	SELL	$143.0 - $274.03 $872,300 - $1.67 Million	-6,100 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $160,732 - $237,402	1,100 Added 22.0%	6,100 $1.26 Million
Q3 2019 Nov 08, 2019	BUY	$130.44 - $187.64 $652,200 - $938,199	5,000 New	5,000 $763,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.